Cite
Rubin DT, Cohen RD, Sandborn WJ, et al. Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis. 2017;11(12):1510doi: 10.1093/ecco-jcc/jjx052.
Rubin, D. T., Cohen, R. D., Sandborn, W. J., Lichtenstein, G. R., Axler, J., Riddell, R. H., Zhu, C., Barrett, A. C., Bortey, E., & Forbes, W. P. (2017). Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. Journal of Crohn's & colitis, 11(12), 1510. https://doi.org/10.1093/ecco-jcc/jjx052
Rubin, David T, et al. "Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial." Journal of Crohn's & colitis vol. 11,12 (2017): 1510. doi: https://doi.org/10.1093/ecco-jcc/jjx052
Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis. 2017 Dec 04;11(12):1510. doi: 10.1093/ecco-jcc/jjx052. PMID: 28453665; PMCID: PMC5951008.
Copy
Download .nbib